Aug 13, 2018 8:30 am EDT Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
Aug 9, 2018 8:30 am EDT VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study
Aug 7, 2018 8:35 am EDT VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update
Jul 2, 2018 8:30 am EDT Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region
May 14, 2018 9:00 am EDT VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018
May 10, 2018 4:05 pm EDT VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update
May 9, 2018 9:00 am EDT VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
